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Embryonic Stem Cells Minireview
Go Dopaminergic
(Bjornson et al., 1999) were shown to regenerate the
entire hematopoietic system in lethally irradiated adult
mice and, in fact, can give rise to most tissues when
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Further, stem cells from bone marrow stroma can give†Genentech, Inc.
rise to brain microglia and astroglia (Eglitis and Mezey,1 DNA Way
1997), bone cartilage, and lung cells (Pereira et al., 1998).South San Francisco, California 94080
Moreover, hematopoetic stem cells can give rise to new
skeletal muscles (Ferrari et al., 1998) and can restore
muscle dystrophin expression (Gussoni et al., 1999). TheOur limited life expectancy, and inevitable death, is
origin of the adult stem cells is not known. They may bebrought about by the ongoing deterioration of the body’s
residual undifferentiated embryonic cells or, as recentessential cell types, tissues, and organs. Thus, either a
evidence suggests, committed/differentiated adult cellsreliable source of replacement organs or cells or a
that reacquire multipotency in response to environmen-method to continually induce the repair of endogen-
tal signals. For example, oligodendrocyte precursorous organs would profoundly affect the current statistics
cells that normally give rise only to oligodendrocytesof aging-related disease and death. The prospect of
can became multipotent neuronal stem cells followinggreater longevity, associated with an increased expec-
sequential exposure to PDGF, bFGF, and BMP2&4tancy of good health, underlies the intense excitement
(Kondo and Raff, 2000).surrounding work on embryonic stem cells. Stem cells
The ability of stem cells to provide us with betterare unique in that they have the capacity for unlimited
health and longevity is dependent on our ability to iden-self-renewal along with the ability to produce multiple
tify the extracellular factors that direct the differentiationdifferent types of terminally differentiated descendants.
of stem cells to a desired lineage. However, most of theThus, they might serve as a multipotential source of
signals that instruct embryonic or adult stem cells toreplacement body parts in cardiovascular, autoimmune,
differentiate to a specific lineage have not yet been iden-Alzheimer’s, or Parkinson’s disease or for diabetes, os-
tified, and thus the resultant ES cell progeny cannot beteoporosis, cancer, spinal cord injury, or birth defects.
controlled. Only recently have efforts to identify suchIdentifying the extrinsic signals that control lineage spe-
factors begun to bear fruit, and last year a group wascific differentiation of stem cells to allow the generation
able to induce ES cells to differentiate to oligoden-of specific tissues in vitro and, eventually in vivo, is a
drocytes and astrocytes in vitro with a high frequency,critical issue in stem cell research.
by sequential exposure to FGF2, EGF, and PDGF. WhenEmbryonic and Adult Stem Cells
transplanted into rats lacking endogenous myelin pro-Have a Lot of Potential
ducing oligodendrocytes, the ES-derived glial precursorStem cells are a major component of the early embryo,
cells differentiated to functional oligodendrocytes, whichbut also exist in many adult tissues. Embryonic stem
were able to myelinate axons in the brain and spinal
(ES) cells are derived from the inner cell mass of the
cord (Liu et al., 2000). Similarly, another group showed
embryonic blastula, and this small group of cells (13 at
that the exposure of ES cells to retinoic acid prompted
the 64 cell stage embryo) will normally give rise to the them to produce glutaminergic, GABAergic, and gly-
entire embryonic yolk sac, the allantois, and the amnion. cinergic neurons (Gottlieb and Huettner, 1999) that,
ES cells can be maintained indefinitely as pluripotent when transplanted into the rat spinal cord 9 days after
stem cells in tissue culture. However, when injected into a traumatic injury, elicited partial functional recovery
the blastocyst of a host mouse embryo, the donor ES (McDonald et al., 1999).
cells integrate into the host inner cell mass and give rise Possible Utility in Parkinson’s Disease
to descendants in all tissues of the resulting chimeric Identifying the conditions required for neural cell induc-
offspring, including germ cells. When injected under the tion of ES cells may be particularly useful for the treat-
skin of an adult nude mouse or grown without essential ment of a progressive neurodegenerative disorder such
growth factors in vitro, ES cells give rise to a random as Parkinson’s disease. Parkinson’s disease (PD), which
collection of differentiated cells and tissues including afflicts over a 1 million people in the US, is characterized
heart, muscle, blood islands, neurons, pigmented cells, by the degeneration and death of midbrain neurons that
macrophages, epithelia, and adipocytes. produce the neurotransmitter dopamine, resulting in
Whereas embryonic stem cells are transient, adult tremors at rest, an inability to initiate or complete routine
stem cells appear to reside permanently in most tissues, movements, muscle rigidity, postural instability, and
including the brain, bone marrow stroma, liver, skin, and lack of facial expression. Transplantation of dopaminer-
muscle. Adult stem cells were initially thought to be gic neurons (DA neurons) taken from human fetuses into
limited in their developmental potential to the regenera- PD patients shows a remarkable, yet inconsistent, ability
tion of cell types comprising their tissues of origin. How- to replace endogenous degenerating DA neurons and
ever, in a recent study, stem cells from the adult brain to ameliorate some of the disease symptoms (Bjorklund
and Lindvall, 2000). However, since treatment of a single
PD patient requires DA neurons from six to ten human‡ To whom correspondence should be addressed (e-mail: mhynes@
concentric.net [M. H.], ar@gene.com [A. R.]). fetuses, replacement therapy is not routinely available.
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Other sources of dopamine producing cells, including neurons, and 7% serotonergic neurons. At the cellular
level, the authors find that 53% of the cells in the culturethose from the adrenal medulla or carotid bodies have
been examined for their ability to alleviate Parkinson’s were tubulin1 neurons, and that 30% of these are dopa-
minergic. Thus, DA neurons represent 16% of the totalsymptoms, but these sources are also limited in num-
bers, and/or are not as effective as fetal DA neurons cell population. While coculture of the ES cells with the
PA6 cell line induces neural differentiation, conditioned(Rosenthal, 1998). An unlimited source of DA neurons
produced in vitro is needed to make transplantation media from PA6 cells does not. However, SDIA is also
not blocked by a 0.4 mm membrane barrier, suggestingavailable to a larger population of PD patients and could
eventually change the transplantation landscape. that the inducing activity is secreted, but may be labile.
Surprisingly, fixation of PA6 cells with paraformaldehydeConversion of ES Cells to Dopaminergic Neurons
Two groups, one in this issue of Neuron, report methods retained the inductive activity of the PA6 membranes
and, in addition, unmasked a similar activity in otherfor generating DA neurons from ES cells and thus open
the way to unlimited in vitro production of these neurons. stromal cell lines that is inactive on live cells. Nonstromal
cells did not show activity, either with or without fixation.One group led by Dr. R. McKay at the NIH (Lee et al.,
2000) took ES cells, dissociated them to single cells, To determine whether SDIA is a general neural in-
ducer, the authors studied its interaction with boneand reaggregated them on nonadherent bacterial cul-
ture plates for 4 days in the presence of serum. This morphogenic proteins (BMPs). The inhibition of BMP
by endogenous organizer-derived molecules (noggin,treatment generated embryoid bodies, floating ES cell
aggregates that contain ectodermal, mesodermal, and chordin, and follistatin) early in development leads to
the formation of neuroectoderm at the expense of ecto-endodermal derivatives. The embryoid bodies were then
plated on adhesive tissue culture plates for 24 hr in demal epidermis. When ES cells are exposed to BMP-4
alone, mesodermal markers are induced. In contrast,the presence of serum and transferred to serum-free
medium for 4–6 days to select for neuronal stem cells. when ES cells are exposed to BMP-4 together with SDIA,
they give rise to epidermal cells. ES cells constitutivelyThese cells were dissociated and grown for 6 days on
an adhesive substrate, in the absence of HEPES but in produce their own BMP, and these findings raised the
possibility that SDIA induces neurogenesis simply bythe presence of FGF8, Shh, and bFGF. Even though
they are essential for the development of midbrain DA acting as an inhibitor of ES cell–derived BMP. However,
when ES-derived BMP is blocked by the addition of aneurons in vivo (Ye et al., 1998), exogenously added Shh
and FGF8 were not essential for the generation of DA soluble BMP receptor–Fc fusion protein that serves as
a functional antagonist of BMP, in the absence of SDIA,neurons from ES cells and increased the yield of ES-
derived DA neurons only 2-fold. bFGF was then re- neuronal differentiation was not elicited. While it remains
possible that the BMP receptor–Fc did not inhibit amoved, and ascorbic acid was added for an additional
6–15 days. The resulting neurons expressed markers member of the BMP protein family that is inhibited by
SDIA, the findings support the idea that SDIA is notthat characterize the embryonic midbrain such as Pax2,
Pax5, Wnt1, and Engrailed1, as well as the DA neuronal acting simply as a BMP antagonist. The effects of SDIA
were also not mimicked by bFGF, FGF8, Shh, HGF, EGF,markers Nurr1 and tyrosine hydroxylase, the rate-lim-
iting enzyme in dopamine synthesis. Furthermore, these PDGF, LIF, Wnt, or a combination of these factors. Taken
together, these findings suggest that SDIA may repre-neurons produced dopamine and released their dopa-
mine upon depolarization with potassium or exposure sent a novel early neural inducer that is required prior
to, or in parallel with, the inhibition of BMP by organizerto the neurotransmitter GABA. Under optimal culture
conditions, 71.9% of the ES cells assumed a neuronal signals. It is of note that recent in vivo evidence for
a positive neural inductive activity that precedes themorphology, 33.9% of the neurons were dopaminergic,
and 11% were serotonergic. inhibition of BMP has been reported to occur in the
normal chick embryo. However, it is not at all clear thatIn a parallel work, a group from Dr. Y. Sasai’s labora-
tory at the RIKEN Center for Developmental Biology in SDIA and this early inducing activity are mediated by
the same factor(s) (Streit et al., 2000).Japan reports in this issue of Neuron a second approach
for the generation of DA neurons from ES cells. In con- To examine the survival of the ES-derived DA neurons
in vivo, isolated SDIA-treated ES cell colonies were trans-trast to the previous protocol, this method does not
require growth in serum, the formation of embryoid bod- planted into the striatum of mice depleted of their endog-
enous DA neurons with the chemical toxin 6-hydroxy-ies, or the selection of neural precursor cells (Kawasaki
et al., 2000). Instead, these authors screened for neu- dopamine. Of 4 3 105 transplanted neurons, (6 3 104
DA neurons), 1.3 3 104 DA neurons were observed inronal differentiation of ES cells after coculture with vari-
ous cell lines and discovered that the bone marrow– the transplants after 2 weeks, a survival rate of 22%,
which is significantly better than the z5% survival ratederived stromal cell line, PA6, is a potent inducer of
neuronal differentiation. They call this activity stromal observed with fetal DA neurons.
Obviously, to be clinically useful and biologicallycell–derived inducing activity (SDIA). After coculture
with PA6 cells, 92% of ES cell colonies contain differenti- meaningful, the molecular identity of SDIA will have to
be elucidated. The authors suggested that the primaryated neurons characterized by positive staining for nes-
tin, tubulin, NCAM, Map2, neurofilament, and synapto- function of SDIA is to generate neuroectoderm and that
the resultant differentiation of DA neurons (and the otherphysin. In contrast, less than 2% of the colonies have
cells that differentiate to the glial or mesodermal lin- neuronal types) is a secondary event. However, the fact
that 30% of the SDIA-induced neurons are DA appearseages. Within the neuronal colonies, 92% contain TH1,
DBH2, Nurr11, Ptx31, dopamine-producing DA neu- inconsistent with this idea. In vivo, DA neurons consti-
tute only 1 in 105 neurons, and their high proportion inrons; 43% contain GABAergic neurons, 28% cholinergic
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Figure 1. Schemata Depicting Two Procedures by which ES Cells Are Induced to Adopt the DA Lineage
KRS, knockout serum replacement medium; FCS, fetal calf serum; EB, embryoid bodies; LIF, leukemia inhibitory factor; Shh, sonic hedgehog;
FGF8, fibroblast growth factor 8; TuJ-1, class-III b-tubulin.
the SDIA-treated ES cells suggests a direct influence of After destroying a subset of neocortical neurons that
project to thalamus, these authors observed that a small,at least one of the SDIA activities on the production of
DA neurons or midbrain neuroectoderm from ES cells. but significant number of new neurons were generated
in the damaged region, and some reinnervated the thala-Since ES cells that were exposed to SDIA give rise also
to GABAergic, cholinergic, and serotonergic neurons, mus. Whether the new neurons migrated from the sub-
ventricular zone or were generated locally from corticalthey may be a useful source of transplanted neurons
in other neurodegenerative disorders such as Hunting- stem cells is not known. There is as yet no evidence
that SDIA can promote the differentiation of neuronalton disease, which is associated with degeneration of
GABAergic interneurons in the striatum. stem cells either in vivo or in vitro. However, these results
raise the intriguing possibility that replacement thera-Can the Endogenous Neuronal Stem Cells
Be Manipulated to Become DA Neurons? pies for PD may be possible through manipulation of
endogenous neural precursors, with instructive agentsThe surprising activity of SDIA on ES cells in vitro raises
the question whether the endogenous SDIA is operating like SDIA.
Remaining Issuesin vivo or whether it could be used induce endogenous
neuronal stem cells to become DA neurons in vivo. Adult The demonstration that ES cells can be induced to make
DA neurons is a promising first step toward the use ofstem cells that give rise to functional neurons are gener-
ated in two regions of the adult rodent and human brain, ES cells for replacement therapy in Parkinson’s patients.
However, a number of critical biological and safety is-the subventricular zone of the lateral ventrical and the
subgranular zone of the dentate gyrus. The survival, sues have to be resolved before their clinical utility be-
comes viable. One unresolved biological issue is whyproliferation, and differentiation of these progenitors are
increased in an enriched environment, following exer- there are multiple pathways for the generation of DA
neurons (Figure 1). DA neurons are present in the mid-cise and in response to insult or infusion of growth fac-
tors (Gage, 2000). Until recently, the adult stem cells brain, hypothalamus, retina, and olfactory bulb. More-
over, within the midbrain there are two major subtypeswere thought to be capable of functional integration only
into the olfactory bulb and hippocampus (Gage, 2000). of DA neurons, those in the substantia nigra that inner-
vate the striatum and degenerate in PD, and those inHowever, work from Magavi et al. (2000) has changed
this perspective and suggested that the brain may have the ventral tegmental area that innervate the limbic sys-
tem and are less affected in PD. Thus, the existence ofa larger capacity for self-repair then previously thought.
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Kawasaki, H., Mizuseki, K., Nishikawa, S., Kaneko, S., Kuwana, Y.,multiple differentiation pathways may be important to
Nakanishi, S., Nishikawa, S.-I., and Sasai, Y. (2000). Neuron 28, thisinduce the different classes of DA neurons. Alternatively,
issue, 31–40.the different pathways may operate at different develop-
Kondo, T., and Raff, M. (2000). Science 289, 1754–1757.mental times. For example, the Shh/FGF8 pathway may
Lee, S.H., Lumelsky, N., Studer, L., Auerbach, J.M., and McKay,mediate DA neuron differentiation during embryogene-
R.D. (2000). Nat. Biotechnol. 18, 675–679.
sis (Ye et al., 1998) whereas an SDIA-like activity might
Liu, S., Qu, Y., Stewart, T.J., Howard, M.J., Chakrabortty, S., Hole-operate as an as yet undiscovered repair mechanism
kamp, T.F., and McDonald, J.W. (2000). Proc. Natl. Acad. Sci. USA
for the generation of new DA neurons in the adult brain. 97, 6126–6131.
In addition, it is possible that the two seemingly different Magavi, S.S., Leavitt, B.R., and Macklis, J.D. (2000). Nature 405,
methodologies discussed here converge on a single, 951–955.
common signaling pathway. Finally, it may be that there McDonald, J.W., Liu, X.Z., Qu, Y., Liu, S., Mickey, S.K., Turetsky,
are multiple, independent ways to generate ES-derived D., Gottlieb, D.I., and Choi, D.W. (1999). Nat. Med. 5, 1410–1412.
substantia nigral DA neurons in vitro that do not occur Pereira, R.F., O’Hara, M.D., Laptev, A.V., Halford, K.W., Pollard, M.D.,
Class, R., Simon, D., Livezey, K., and Prockop, D.J. (1998). Proc.in vivo. If true, this suggests that our search for factors
Natl. Acad. Sci. USA 95, 1142–1147.that induce ES cells to adopt a particular fate can be
Rosenthal, A. (1998). Neuron 20, 169–172.assisted, but should not be constrained, by what we
Streit, A., Berliner, A.J., Papanayotou, C., Sirulnik, A., and Stern,know about normal development.
C.D. (2000). Nature 406, 74–78.Regarding the clinical aspects of transplantation, ES
Ye, W., Shimamura, K., Rubenstein, J.L., Hynes, M.A., and Rosen-cells can give rise to teratomas, and further study is
thal, A. (1998). Cell 93, 755–766.necessary to examine the tumorigenic potential of long-
term transplants. Since neither study demonstrated
functional recovery following transplantation, it will also
be important to show that ES-derived DA neurons func-
tion as the endogenous DA neurons do. In addition,
transplantation in human requires 10- to 100-fold more
DA neurons as compared to the rodent model, and it is
not yet clear whether sufficient quantities of DA neurons
can be generated from SDIA-treated or embryoid body–
derived ES cells to have clinical utility. Moreover, the
SDIA-treated ES cells give rise to a mixed population
of neurons, and it will have to be determined whether
the transplanted non-DA neurons exert beneficial or del-
eterious clinical effects (Bjorklund and Lindvall, 2000).
Lastly, although these authors have established condi-
tions for the generation of DA neurons from mouse ES
cells, it remains to be determined whether the same
conditions apply to human ES cells. In sum, we are still
far from an established in vitro or in vivo source of DA
neurons to combat PD. However, the ability to manipu-
late ES cells is important progress, and it can reasonably
be hoped that we will be able to utilize stem cells and
the factors that influence their differentiation as powerful
therapeutic agents for PD and other human disorders
in the foreseeable future.
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